Andrew Parker
Chief Executive Officer at ArisGen SA
Andrew Parker active positions
Companies | Position | Start | End |
---|---|---|---|
ArisGen SA
ArisGen SA Pharmaceuticals: MajorHealth Technology ArisGen SA manufactures novel products. The private company is based in Plan-les-Ouates, Switzerland. The CEO of the Swiss company is Andrew Parker. | Chief Executive Officer | - | - |
Step Pharma SAS
Step Pharma SAS Pharmaceuticals: MajorHealth Technology Step Pharma SAS develops drugs for immunosuppressive therapies. The company was founded by Geoffroy de Ribains, Alain Fischer, and Sylvain Latour and is headquartered in Paris, France. | Director/Board Member | 2019-09-04 | - |
Chief Executive Officer | 2019-09-04 | - |
Career history of Andrew Parker
Former positions of Andrew Parker
Companies | Position | Start | End |
---|---|---|---|
ZEALAND PHARMA A/S | Chief Tech/Sci/R&D Officer | 2016-06-30 | 2019-08-30 |
Eclosion2 SA
Eclosion2 SA Financial ConglomeratesFinance Eclosion2 SA provides financial services. | Corporate Officer/Principal | - | - |
Eclosion2 & Cie Scpc | Corporate Officer/Principal | - | - |
SHIRE | Corporate Officer/Principal | - | - |
GENEURO SA | Director/Board Member | - | - |
Independent Dir/Board Member | - | - | |
Beerse Betonhandel
Beerse Betonhandel Regional BanksFinance Part of Douterloigne Betonwerken, Beerse Betonhandel is a Belgian company that has a description related to depository banking functions not classified elsewhere. Beerse Betonhandel was acquired by Douterloigne Betonwerken on February 01, 1999. | Corporate Officer/Principal | - | - |
Janssen Pharmaceutica NV
Janssen Pharmaceutica NV Pharmaceuticals: MajorHealth Technology Janssen Pharmaceutica NV engages in the development of medical solutions. It offers research and development services in the field of mental illness, neurological disorders, anesthesia, analgesia, gastrointestinal disorders, fungal infection, allergies and cancer. The firms products include Zytiga, Caelyx, Dacogen, Edurant, Fentanyl-Janssen, Intelence, Leustatin, , Pariet, and Reminyl. The company was founded in 1953 by Paul Janssen and is headquartered in Beerse, Belgium. | Corporate Officer/Principal | - | - |
░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
Training of Andrew Parker
The National Institute For Medical Research | Doctorate Degree |
Warwick Business School | Masters Business Admin |
Statistics
International
Switzerland | 5 |
United Kingdom | 4 |
Ireland | 3 |
Operational
Corporate Officer/Principal | 6 |
Chief Tech/Sci/R&D Officer | 2 |
Director/Board Member | 2 |
Sectoral
Health Technology | 9 |
Consumer Services | 3 |
Finance | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
ASTRAZENECA PLC | Health Technology |
GENEURO SA | Health Technology |
ZEALAND PHARMA A/S | Health Technology |
Private companies | 8 |
---|---|
Opsona Therapeutics Ltd.
Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland. | Health Technology |
Janssen Pharmaceutica NV
Janssen Pharmaceutica NV Pharmaceuticals: MajorHealth Technology Janssen Pharmaceutica NV engages in the development of medical solutions. It offers research and development services in the field of mental illness, neurological disorders, anesthesia, analgesia, gastrointestinal disorders, fungal infection, allergies and cancer. The firms products include Zytiga, Caelyx, Dacogen, Edurant, Fentanyl-Janssen, Intelence, Leustatin, , Pariet, and Reminyl. The company was founded in 1953 by Paul Janssen and is headquartered in Beerse, Belgium. | Health Technology |
Beerse Betonhandel
Beerse Betonhandel Regional BanksFinance Part of Douterloigne Betonwerken, Beerse Betonhandel is a Belgian company that has a description related to depository banking functions not classified elsewhere. Beerse Betonhandel was acquired by Douterloigne Betonwerken on February 01, 1999. | Finance |
Eclosion2 & Cie Scpc | |
ArisGen SA
ArisGen SA Pharmaceuticals: MajorHealth Technology ArisGen SA manufactures novel products. The private company is based in Plan-les-Ouates, Switzerland. The CEO of the Swiss company is Andrew Parker. | Health Technology |
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Eclosion2 SA
Eclosion2 SA Financial ConglomeratesFinance Eclosion2 SA provides financial services. | Finance |
Step Pharma SAS
Step Pharma SAS Pharmaceuticals: MajorHealth Technology Step Pharma SAS develops drugs for immunosuppressive therapies. The company was founded by Geoffroy de Ribains, Alain Fischer, and Sylvain Latour and is headquartered in Paris, France. | Health Technology |
- Stock Market
- Insiders
- Andrew Parker
- Experience